Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.
The target of neutralizing antibodies that protect against influenza virus infection is the viral protein HA. Genetic and antigenic variation in HA has been used to classify influenza viruses into subtypes (H1-H16). The neutralizing antibody response to influenza virus is thought to be specific for a few antigenically related isolates within a given subtype. However, while heterosubtypic antibodies capable of neutralizing multiple influenza virus subtypes have been recently isolated from phage display libraries, it is not known whether such antibodies are produced in the course of an immune response to influenza virus infection or vaccine. Here we report that, following vaccination with seasonal influenza vaccine containing H1 and H3 influenza virus subtypes, some individuals produce antibodies that cross-react with H5 HA. By immortalizing IgG-expressing B cells from 4 individuals, we isolated 20 heterosubtypic mAbs that bound and neutralized viruses belonging to several HA subtypes (H1, H2, H5, H6, and H9), including the pandemic A/California/07/09 H1N1 isolate. The mAbs used different VH genes and carried a high frequency of somatic mutations. With the exception of a mAb that bound to the HA globular head, all heterosubtypic mAbs bound to acid-sensitive epitopes in the HA stem region. Four mAbs were evaluated in vivo and protected mice from challenge with influenza viruses representative of different subtypes. These findings reveal that seasonal influenza vaccination can induce polyclonal heterosubtypic neutralizing antibodies that cross-react with the swine-origin pandemic H1N1 influenza virus and with the highly pathogenic H5N1 virus.
Corti
Davide
D
Institute for Research in Biomedicine, Bellinzona, Switzerland.
Suguitan
Amorsolo L
AL
Pinna
Debora
D
Silacci
Chiara
C
Fernandez-Rodriguez
Blanca M
BM
Vanzetta
Fabrizia
F
Santos
Celia
C
Luke
Catherine J
CJ
Torres-Velez
Fernando J
FJ
Temperton
Nigel J
NJ
Weiss
Robin A
RA
Sallusto
Federica
F
Subbarao
Kanta
K
Lanzavecchia
Antonio
A
D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry; D057134:Antibodies, Neutralizing / Q000737:chemistry*; D001665:Binding Sites; D004285:Dogs; D018604:Epitope Mapping / Q000379:methods; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control*; D007963:Leukocytes, Mononuclear / Q000166:cytology; D051379:Mice; D008807:Mice, Inbred BALB C; D009154:Mutation; D009975:Orthomyxoviridae / Q000378:metabolism; D011485:Protein Binding
D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D007074:Immunoglobulin G; D007252:Influenza Vaccines
PLoS One. 2008;3(12):e3942
19079604
Science. 2009 Apr 10;324(5924):246-51
19251591
Nature. 1981 Jan 29;289(5796):373-8
6162101
Emerg Infect Dis. 2008 Jan;14(1):121-8
18258091
Virology. 2004 Aug 1;325(2):287-96
15246268
Nat Med. 2004 Aug;10(8):871-5
15247913
PLoS Med. 2009 Apr 21;6(4):e1000049
19381279
Microbiol Rev. 1992 Mar;56(1):152-79
1579108
Annu Rev Biochem. 2000;69:531-69
10966468
J Exp Med. 1966 Sep 1;124(3):331-45
5922742
Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1871-6
11779386
Nat Med. 2009 Nov;15(11):1251-2
19893556
Influenza Other Respir Viruses. 2007 May;1(3):105-12
19453415
Virology. 2006 Sep 1;352(2):418-26
16777168
J Clin Invest. 1996 May 1;97(9):2074-80
8621797
Nature. 1981 Jan 29;289(5796):366-73
7464906
J Virol. 2005 Mar;79(5):2814-22
15709000
J Immunol. 1979 Aug;123(2):825-32
88484
Immunology. 2006 Sep;119(1):1-7
16925526
Science. 2004 Jul 16;305(5682):371-6
15218094
Acta Virol. 1999 Aug;43(4):237-44
10749369
J Virol. 2002 Feb;76(3):1369-78
11773411
Nat Struct Mol Biol. 2009 Mar;16(3):265-73
19234466
PLoS Pathog. 2009 Jun;5(6):e1000482
19557166
J Virol. 1986 Jan;57(1):124-8
3941436
Nature. 2007 Sep 6;449(7158):101-4
17805298
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):5986-91
18413603
PLoS Med. 2006 Sep;3(9):e360
16968127
J Virol. 1993 May;67(5):2552-8
7682624
Annu Rev Immunol. 1990;8:737-71
2188678
J Virol. 1994 Jan;68(1):517-20
8254764
Vaccine. 2009 Oct 9;27(43):5998-6003
19665606
Eur J Immunol. 2009 May;39(5):1260-70
19404981
J Clin Microbiol. 1999 Apr;37(4):937-43
10074505
Cell. 1982 Dec;31(2 Pt 1):417-27
6186384
PLoS Pathog. 2009 Mar;5(3):e1000350
19300497